BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab

NCT03020602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Gliosarcoma
Recurrent Glioblastoma
Astrocytoma of Brain
Glioblastoma

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Ubidecarenone Injectable Nanosuspension

Sponsor

Seema Nagpal